Clinical Trials Directory

Trials / Completed

CompletedNCT02055378

the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Not accepted

Summary

To compare the effect of myopia control between patients treated with low-concentration atropine eye drops combined with auricular acupoint stimulation and those treated with atropine alone.

Detailed description

Myopia has been an increasing problem among school children, especially in Asian countries. High myopia is not only a refractive problem, but also a disease that can result in a number of sight-threatening complications such as macular degeneration, retinal detachment, glaucoma, and cataract. Atropine is a long-acting non-selective muscarinic antagonist that blocks accommodation by paralyzing ciliary muscles; it may affect remodeling of the sclera and suppress the elongation of axial length. Acupuncture and acupressure have been widely used in traditional Chinese medicine for thousands of years. Auricular acupoint stimulation by acupuncture or acupressure has been reported to improve visual acuity in myopic patients. Therefore, we want to compare the effect of myopia control between patients treated with low-concentration atropine eye drops combined with auricular acupoint stimulation and those who treated with atropine alone.

Conditions

Interventions

TypeNameDescription
DRUGAtropinetopical 0.125% atropine eye drops
DEVICEauricular acupoint stimulationFive auricular acupoints (Shenmen, Xin, Yan, Mu 1 and Mu 2) Tapping stimulation was administered by using a 1-mm alloy ball (Magrain®; Sakamura, Kyoto, Japan) three times a day, each time for five minutes.

Timeline

Start date
2011-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2014-02-05
Last updated
2014-02-05

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02055378. Inclusion in this directory is not an endorsement.